Corient Private Wealth LLC Grows Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

Corient Private Wealth LLC boosted its position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 1,281.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 188,591 shares of the technology company's stock after buying an additional 174,936 shares during the period. Corient Private Wealth LLC owned 0.12% of Veeva Systems worth $39,651,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in VEEV. Toronto Dominion Bank increased its position in Veeva Systems by 39.1% during the 3rd quarter. Toronto Dominion Bank now owns 20,180 shares of the technology company's stock worth $4,235,000 after purchasing an additional 5,673 shares during the period. Principal Financial Group Inc. increased its holdings in Veeva Systems by 138.9% in the third quarter. Principal Financial Group Inc. now owns 2,179,284 shares of the technology company's stock valued at $457,366,000 after buying an additional 1,267,061 shares in the last quarter. Smith Group Asset Management LLC increased its holdings in Veeva Systems by 2.2% in the fourth quarter. Smith Group Asset Management LLC now owns 82,567 shares of the technology company's stock valued at $17,360,000 after buying an additional 1,749 shares in the last quarter. Everence Capital Management Inc. acquired a new stake in shares of Veeva Systems during the 4th quarter valued at approximately $816,000. Finally, Venturi Wealth Management LLC boosted its stake in shares of Veeva Systems by 2,716.7% during the 4th quarter. Venturi Wealth Management LLC now owns 169 shares of the technology company's stock worth $36,000 after acquiring an additional 163 shares in the last quarter. Hedge funds and other institutional investors own 88.20% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several brokerages recently issued reports on VEEV. Bank of America lifted their price objective on Veeva Systems from $280.00 to $290.00 and gave the stock a "neutral" rating in a report on Friday, December 6th. Citigroup boosted their price objective on shares of Veeva Systems from $281.00 to $307.00 and gave the stock a "buy" rating in a research report on Monday, December 9th. Wells Fargo & Company raised their target price on shares of Veeva Systems from $275.00 to $285.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Morgan Stanley upped their price target on shares of Veeva Systems from $195.00 to $201.00 and gave the company an "underweight" rating in a report on Thursday, March 6th. Finally, Truist Financial raised their price objective on shares of Veeva Systems from $210.00 to $217.00 and gave the stock a "hold" rating in a research note on Thursday, March 6th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $256.52.

Veeva Systems Stock Up 0.5 %

Shares of NYSE VEEV traded up $1.13 during trading on Friday, hitting $236.98. 1,192,386 shares of the company traded hands, compared to its average volume of 1,008,032. The firm has a market capitalization of $38.47 billion, a P/E ratio of 58.51, a P/E/G ratio of 1.89 and a beta of 0.88. The company has a 50-day moving average price of $228.86 and a 200-day moving average price of $222.03. Veeva Systems Inc. has a 1 year low of $170.25 and a 1 year high of $258.93.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.